LGP — Little Green Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Little Green Pharma, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.

	R2021 June 30th	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	9 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7	10.5	19.9	25.6	36.8
Cost of Revenue
Gross Profit	4.24	3.38	10.1	13.6	24.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	-11.9	29.5	32.2	34.8	41.2
Operating Profit	18.9	-19	-12.3	-9.16	-4.38
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	22.2	-18.1	-8.56	-8.15	-4.79
Provision for Income Taxes
Net Income After Taxes	22.2	-18.1	-8.56	-8.15	3.32
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	22.2	-18.3	-9.21	-8.15	3.32
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	22.2	-18.3	-9.21	-8.15	3.32
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.015	-0.086	-0.034	-0.025	0.012
Dividends per Share